{"id":"W2014561045","doi":"10.1016/j.ahj.2014.07.028","title":"Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial","year":2014,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":411,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Canadian VIGOUR Centre","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Alirocumab; PCSK9; Monoclonal; Monoclonal antibody; Term (time); Internal medicine; Intensive care medicine; Antibody; Immunology; Cholesterol; LDL receptor; Lipoprotein","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005841469,0.001567325,0.002315339,0.0002766351,0.0006162097,0.001311981,0.000901664,0.00185341,0.003244088],"category_scores_gemma":[0.005127663,0.0003905687,0.001727819,0.0003776748,0.001263338,0.0008850115,0.0007150262,0.002498893,0.0005901741],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006312645,"about_ca_system_score_gemma":0.001431326,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008093332,"about_ca_topic_score_gemma":0.001651473,"domain_scores_codex":[0.9972821,0.001874242,0.0001329683,0.0002946348,0.0002085963,0.0002073742],"domain_scores_gemma":[0.9981987,0.0004739277,0.0003919867,0.0001597712,0.0001887675,0.0005870046],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.920084,0.00824187,0.008947386,0.002518629,0.002925669,0.0001096512,0.0001364769,0.0010572,0.001988833,0.001328529,0.003332873,0.04932889],"study_design_scores_gemma":[0.9239652,0.05172188,0.01336904,0.0003753747,0.002340858,0.00009936634,0.00005179397,0.001114703,0.0005324137,0.001451359,0.004930009,0.00004801643],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9086614,0.03583835,0.002673771,0.007120244,0.00186181,0.02599609,0.003721322,0.0001239806,0.01400292],"genre_scores_gemma":[0.9498908,0.008122948,0.005286999,0.005338144,0.001602537,0.02323839,0.002539224,0.00003106252,0.003949995],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.005841469,"threshold_uncertainty_score":0.03089297,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02261382628838262,"score_gpt":0.3292959977167019,"score_spread":0.3066821714283193,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}